Sergott covers the Healthcare sector, focusing on stocks such as Pacific Biosciences, Charles River Labs, and Quest Diagnostics. Icon has an analyst consensus of Strong Buy, with a price target ...
Zacks Investment Research on MSN3h
Pacific Biosciences of California (PACB) Increases Yet Falls Behind Market: What Investors Need to KnowPacific Biosciences of California (PACB) ended the recent trading session at $1.22, demonstrating a +1.67% swing from the preceding day's closing price. The stock's change was less than the S&P 500's ...
In the last three months, 4 analysts have published ratings on Pacific Biosciences (NASDAQ:PACB), offering a diverse range of perspectives from bullish to bearish. In the table below, you'll find ...
24d
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Siegfried Holding AG (SGFEF – Research Report) and Icon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback